| This week's sponsor is Ajinomoto Bio-Pharma Services. | |  | |
Today's Rundown Featured Story | | | Tuesday, March 12, 2019 President Trump’s budget proposals for 2020 are in, seeking a cut for the National Institutes of Health (NIH) for the third year in a row but an increase in the FDA’s finances. |
|
|
Top Stories Tuesday, March 12, 2019 Microsoft aims to bring its coding skills to bear on biotech, with the goal of building an end-to-end platform for programming the biology of living cells to better produce new medicines and potentially materials that could be applicable to a range of industries. Tuesday, March 12, 2019 The European Medicines Agency (EMA) has officially begun operating out of its new temporary home in Amsterdam. Staff will move into the offices throughout the coming week having left the U.K. as it enters a critical moment in the Brexit process. Monday, March 11, 2019 Strengthen Your Protocol With Patient Insights. See how Covance helps sponsors reduce patient burden to increase participation and improve patient retention. Tuesday, March 12, 2019 AstraZeneca has teamed up with Seres Therapeutics to explore whether microbiome therapeutics can increase the efficacy of cancer immunotherapies. The deal will see AstraZeneca pay $20 million to collaborate with Seres and test SER-401 in combination with its oncology assets. Monday, March 11, 2019 AbbVie and Principia are ending an autoimmunity-focused partnership, with Principia regaining the rights to the immunoproteasome inhibitor program. Under the deal, the pair shared research and preclinical work after which AbbVie could take "viable compounds" forward. Tuesday, March 12, 2019 Tiburio Therapeutics is wasting no time in getting its executives in order, nabbing Avrobio’s former chief medical officer Nerissa Kreher, M.D., as its own. Tuesday, March 12, 2019 Neurocrine Biosciences' treatment for congenital adrenal hyperplasia put up positive interim data in a phase 2 study, significantly lowering levels of two types of hormones linked to the rare genetic disorder in more than half of the patients. Resources Sponsored by: Patheon, part of Thermo Fisher Scientific The Right Partner Can Improve Flexibility and Mitigate Risks from Forecast Inaccuracy in Biomanufacturing. Sponsored by: Patheon, part of Thermo Fisher Scientific Download this whitepaper to learn more. Sponsored by: ON24 Which HCP Touchpoints and channels are yielding the best results in today’s digital world? Sponsored by: Blue Matter White paper outlining the key types of cell-based immunotherapies in oncology, as well as the development and commercial outlook for each. Sponsored by: AlphaSense It’s never been more challenging to stay on top of trends and innovation shaping the future of healthcare. Discover how AI can help competitive intelligence teams achieve more proactive strategies. Sponsored by: Outer Edge Technology With FDA approval imminent, start-up Life Sciences company partners with an industry focused MSP to design and manage its regulated cloud-based infrastructure to speed time to market. Presented by: Veeva Share your thoughts on the life sciences industry's progress in improving study execution. Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. | 
